Malaria Protection of the International Traveler

1993 ◽  
Vol 14 (3) ◽  
pp. 155-160 ◽  
Author(s):  
M. Sigfrido Rangel-Frausto ◽  
Michael B. Edmond

Although isolated cases of malaria still may be acquired in the United States,’ imported cases in international travelers are primarily responsible for approximately 1,000 cases reported annually to the Centers for Disease Control and Prevention (CDC). In the decade ending in 1988, more than 50 malaria-associated deaths were reported, most of them theoretically preventable. Moreover, it is estimated that only 30% to 60% of malaria cases are actually reported to the CDC.In recent years, an increase in infections due to Plasmodium falciparum, which accounts for the most severe form of malaria, has been noted. This increase is multifactorial in origin and is associated with an increase in travel to malarious areas, difficulties with chemoprophylaxis (including compliance and adverse effects), and increasing resistance to multiple antimalarial agents. Thus, careful counseling of the traveler and appropriate chemoprophylaxis remain vitally important.

2019 ◽  
pp. 197-222
Author(s):  
Janet R. Gilsdorf

The success of the conjugate Hib vaccines has been spectacular. Prior to their introduction, an estimated 10,000 cases of Hib meningitis occurred annually in the United States, which was approximately 1 in 300 children. It was even higher among native Alaskan and American Indian children. Since the widespread use of the vaccine, the disease has nearly disappeared in the United States, with only 40 cases in children under age 5 years reported by the Centers for Disease Control and Prevention in 2014. Thus, bacterial meningitis, once a scourge that killed and damaged too many American children is, for the most part, now a bad memory.


2009 ◽  
Vol 7 (4) ◽  
pp. 9
Author(s):  
Atresha Karra, JD ◽  
Emily Cornette, JD

This article focuses on the existing methods for tracking and restricting the spread of communicable diseases, both within United States borders and across nations. It will first describe the roles played by the United States’ Centers for Disease Control and Prevention and the World Health Organization and will then explore how communicable diseases across the world are identified and monitored. This will be followed by a discussion of US and world reporting requirements and methods. Finally, the article will discuss the tactics used by the United States to control the spread of disease.


2016 ◽  
Vol 54 (2) ◽  
pp. 106-111 ◽  
Author(s):  
DeLawnia Comer-HaGans ◽  
Shamly Austin ◽  
Zo Ramamonjiarivelo

Abstract According to 2010 data from the Centers for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death in the United States. It is assumed that various diabetes interventions are available to help individuals manage this chronic disease, but that is not the case. The literature is scant regarding interventions focused on people with disabilities who have diabetes. The purpose of this article is to review interventions specifically focused on people with disabilities who have diabetes and to discuss the effect of these interventions on this population.


2002 ◽  
Vol 6 (20) ◽  
Author(s):  
C McGarrigle

The United States (US) Centers for Disease Control and Prevention has published new guidelines for the treatment of sexually transmitted diseases (STDs) (1). The guidelines are for physicians and other healthcare providers who prevent and treat sexually transmitted diseases (STDs).


2001 ◽  
Vol 5 (51) ◽  
Author(s):  
R Harling

The Centers for Disease Control and Prevention (CDC) in the United States (US) last week released its plans to cope with a deliberate release of smallpox (1). The plan centres on rapid ring vaccination of the contacts of infected individuals to contain the spread of infection. Mass vaccination in advance of an outbreak will not be used, partly because the risks associated with vaccination outweigh the risks of exposure to smallpox.


Author(s):  
Philip J. Landrigan ◽  
Mary M. Landrigan

Each year, poison-control centers across the country receive thousands of calls from frantic parents whose children have accidentally ingested toxic chemicals, prescription drugs, and even toxic houseplants. According to the Centers for Disease Control and Prevention, every day 300 children across the United States are...


2009 ◽  
Vol 27 (1) ◽  
pp. 45-61
Author(s):  
Rachel L. Mathers

Abstract This paper determines whether there exists a public goods problem pertaining to AIDS prevention spending, which is measured using Center for Disease Control and Prevention (CDC) AIDS prevention policy cost data for the United States over the years 1998-2007. Panel regressions are utilized to measure the degree to which AIDS prevention is a public good. If prevention spending is a Samuelsonian public good, the costs of such programs should not be a function of the number of people covered by the program. The results of this analysis have important implications for the funding of AIDS prevention programs and indicate that this spending has spillover benefits.


Sign in / Sign up

Export Citation Format

Share Document